However, based on current research, retatrutide may be a good fit for those who: Are obese or overweight Have type 2 diabetes Live with fatty liver disease Have high blood pressure Have sleep apnea She adds it may not be a good fit for those with: A history of pancreatitis Certain thyroid cancers (such as medullary thyroid carcinoma) Specific digestive conditions (such as severe gastroparesis) People who are pregnant or breastfeeding Similar to many medications, retatrutide is not without side effects
In the Look AHEAD study, which examined the effect of intensive lifestyle intervention in patients with obesity and type 2 diabetes, the composite endpoint of adverse cardiovascular events and mortality was reduced by approximately 20% over a median follow-up period of 10.2 years, only in the group of patients that achieved a weight loss of 10% or more from their initial body weight (about 40% of the intervention arm) [7, 8]
doi:10.1016/J.AJO.2004.10.022 6
Oral melanoacanthoma: case series of 33 cases and review of the literature
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide receptor
The rice, like all the rice dishes in my box, was mushy and wet
